Adjuvant chemotherapy for rectal cancer - Authors' reply

The Lancet Oncology

Volumn 15, Issue 6, 2014, Pages

  Bosset, Jean François ^a   Collette, Laurence ^b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; COLON CANCER; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; DRUG TOLERABILITY; ECHOGRAPHY; HUMAN; ILEOSTOMY; LETTER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; TREATMENT DURATION; TUMOR LOCALIZATION;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; RECTAL NEOPLASMS;

EID: 84899734873     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70128-7     Document Type: Letter

References (13)

1. Bosset JF, Calais G, Mineur L, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 2014, 15:184-190.
2. You K, Huang R, Gao Y Adjuvant chemotherapy for rectal cancer. Lancet Oncol 2014, 15:e194.
3. Bujko K, Glimelius B Adjuvant chemotherapy for rectal cancer. Lancet Oncol 2014, 15:e194.
4. Collette L, Bosset JF, den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007, 25:4379-4386.
5. Valsecchi ME Adjuvant chemotherapy for rectal cancer. Lancet Oncol 2014, 15:e195.
6. Atkins CD Adjuvant chemotherapy for rectal cancer. Lancet Oncol 2014, 15:e195.
7. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999, 17:1356-1363. International multicentre pooled analysis of B2 colon cancer trials (IMPACT B2).
8. Khrizman P, Niland JC, ter Veer A, et al. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy : a national comprehensive cancer network analysis. J Clin Oncol 2013, 31:30-38.
9. Thornton M, Rooney PS Adjuvant chemotherapy for rectal cancer. Lancet Oncol 2014, 15:e196.
10. Den Dulk M, Collette L, van de Velde CJH, et al. Quality of surgery in T3-4 rectal cancer : involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC 22921. Eur J Cancer 2007, 43:1821-1828.
11. National bowel cancer audit HSCIC, (accessed April 10, 2014). http://www.hscic.gov.uk/bowel.
12. Nicholls RJ, York Mason A, Morson BC, Dixon AK, Kelsey Fry I The clinical staging of rectal cancer. Br J Surg 1982, 69:404-409.
13. Williams NS, Jass JR, Hardcastle JD Clinicopathological assessment and staging of colorectal cancer. Br J Surg 1988, 75:649-652.